Who earned more than most CEOs?

Posted 26 March 2024 PM

Johnson & Johnson's head of Pharmaceutical R&D, John Reed, has made AU$30 million in his first year at the company, earning more than many Big Pharma CEOs.

While his package fell short of that of his boss - CEO Joaquin Duato who earned AU$42 million in 2023 - Reed's stellar earnings put him ahead of European big pharma chiefs including GSK's Emma Walmsley who, even after a pay rise, earned less at AU$24 milllion, Novartis' Vas Narasimhan on AU$23 million, Sanofi's Paul Hudson on AU$17.5 million, Roche's Thomas Schinecker AU$16.6 million and Novo Nordisk's Lars Jorgensen on AU$15.1 million.

To see the whole article, please login